Hired in Q3 2021
Former president of Dialco Medical Inc.
23 years in medical devices (clinical development, commercialization, regulatory and manufacturing).
31 years in product development
14 years of gait analysis and exoskeleton design and development experience.
Past experience with Delta Q, Ciena Networks, Nortel
Extensive public and private company CFO experience.
FABRIZIO BROCCHIERI – DIRECTOR
Fabrizio Brocchieri is an experienced financial advisor and executive with over 25 years of practice in execution and financing of M&A transactions. He has also been chief financial officer and board member of a renewable energy company from the start-up phase until the financial sponsor exit, through the international expansion and strategic re-positioning of the sustainable E-mobility business. Fabrizio spent most of his professional career working for Deutsche Bank Corporate and Investment Banking, Intesa Sanpaolo International Banking Division and he is currently managing director of Capital Insight Partners, an independent financial advisory boutique. Fabrizio graduated from the Università Cattolica del Sacro Cuore, and lives in Milan with his wife and four children.
Dr. Selber is an orthopedic surgeon who has been involved in the treatment of gait and movement disorders in pediatric, adolescent, and adult patients for more than 25 years. He specializes in conditions such as cerebral palsy, spina bifida and several neuromuscular conditions. Early in 2022, Dr. Selber joined HSS where he collaborates with the Dr. Leon Root Motion Analysis Laboratory and continues to care for ambulatory and non-ambulatory children and adults with cerebral palsy.
Dr. Scher is a Professor of Clinical Orthopaedic Surgery at Weill Cornell Medical College and an Attending Orthopaedic Surgeon in the Division of Pediatric Orthopaedic Surgery at Hospital for Special Surgery in New York City, where he is co-medical director of the Leon Root Motion Analysis Lab.
Dr. Alvarez is a Clinical Professor in the Division of Paediatric Orthopaedic Surgery at the British Columbia Children’s Hospital, University of British Columbia. She has been a faculty member for 22 years and a clinical member/ co-director of the Shriner’s Gait Lab since 2000. Her clinical expertise includes paediatric foot and ankle conditions, Hereditary Multiple Exostosis, spinal cord clinic including congenital and acquired conditions, cerebral palsy, arthrogryposis and gait analysis. She founded and has maintained specialty clinics for HME and complex foot deformities including clubfoot. Dr. Alvarez has been part of impactful committees at the local, national and international level: including the teaching faculty, Advisory Committee for the International Society for Arhrogryposis, Steering Committee for Canadian Botulinum Toxin conference, Orthopaedic Redesign Committee, Trauma Committee and Computer Services Transformation.
Dr. Bulea received his Ph.D. in biomedical engineering from Case Western Reserve University and is a Tenure Track Investigator in the Rehabilitation Medicine Department at the National Institutes of Health in Bethesda, MD. Dr. Bulea’s research focuses on integration of neural interfacing with rehabilitation robotics to develop new therapeutic tools and interventions for treatment of movement disorders and paralysis. Dr. Bulea is the principal investigator on the NIH trial of the Agilik and a co-inventor of the Agilik system.
Dr. Thomas C. Bulea is an employee of the NIH Clinical Center which is part of the National Institutes of Health, an Agency under the US Department of Health and Human Services. Any reference to NIH or to Dr. Bulea should not be viewed as an endorsement of Bionic Power, Inc., its products or services.
Dr. Selber is an orthopedic surgeon who has been involved in the treatment of gait and movement disorders in pediatric, adolescent, and adult patients for more than 25 years. He specializes in conditions such as cerebral palsy, spina bifida and several neuromuscular conditions. Early in 2022, Dr. Selber joined HSS where he collaborates with the Dr. Leon Root Motion Analysis Laboratory and continues to care for ambulatory and non-ambulatory children and adults with cerebral palsy.
Dr. Scher is a Professor of Clinical Orthopaedic Surgery at Weill Cornell Medical College and an Attending Orthopaedic Surgeon in the Division of Pediatric Orthopaedic Surgery at Hospital for Special Surgery in New York City, where he is co-medical director of the Leon Root Motion Analysis Lab.
Dr. Bulea received his Ph.D. in biomedical engineering from Case Western Reserve University and is a Tenure Track Investigator in the Rehabilitation Medicine Department at the National Institutes of Health in Bethesda, MD. Dr. Bulea’s research focuses on integration of neural interfacing with rehabilitation robotics to develop new therapeutic tools and interventions for treatment of movement disorders and paralysis. Dr. Bulea is the principal investigator on the NIH trial of the Agilik and a co-inventor of the Agilik system.
Dr. Thomas C. Bulea is an employee of the NIH Clinical Center which is part of the National Institutes of Health, an Agency under the US Department of Health and Human Services. Any reference to NIH or to Dr. Bulea should not be viewed as an endorsement of Bionic Power, Inc., its products or services.
Dr. Alvarez is a Clinical Professor in the Division of Paediatric Orthopaedic Surgery at the British Columbia Children’s Hospital, University of British Columbia. She has been a faculty member for 22 years and a clinical member/ co-director of the Shriner’s Gait Lab since 2000. Her clinical expertise includes paediatric foot and ankle conditions, Hereditary Multiple Exostosis, spinal cord clinic including congenital and acquired conditions, cerebral palsy, arthrogryposis and gait analysis. She founded and has maintained specialty clinics for HME and complex foot deformities including clubfoot. Dr. Alvarez has been part of impactful committees at the local, national and international level: including the teaching faculty, Advisory Committee for the International Society for Arhrogryposis, Steering Committee for Canadian Botulinum Toxin conference, Orthopaedic Redesign Committee, Trauma Committee and Computer Services Transformation.
CONTACT US
SUPPORT
OUR PRIVACY PAGE
© 2023 Bionic Power Inc.
CONTACT US
SUPPORT
OUR PRIVACY PAGE
© 2023 Bionic Power Inc.